Search

everythinglearnresearchcommunity

for

Search:↓

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Promising cancer treatments were found, but the manufacturer closed.

The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.

Bimekizumab quickly improves psoriasis symptoms and skin at the molecular level.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Pediatric systemic lupus erythematosus is a severe autoimmune disease in children requiring early diagnosis and comprehensive management.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.